Market Analysis
Product Positioning
Competitor Monitoring
Find Global Buyers
Find Contact Information
Company Comparison
Supply Chain Optimization
Email Marketing
Customer Management
Blog
FAQs
About Topease
Agency Program
Costa RicaLisan S.A., also known as Laboratorios Lisan, is a Costa Rican pharmaceutical company founded in 1980 by Dr. Carlos Carboni Escalante. It produces high-quality generic medications for both human and veterinary use, including tablets, capsules, creams and ointments, syrups, suspensions, and granules, all under quality standards set by the Costa Rican Ministry of Health. The company operates three divisions: human generics, veterinary products, and a natural plant-based line (Lisanatura). It supplies major pharmaceutical distributors serving more than 500 pharmacies across Costa Rica and exports to several Central American countries and the U.S. market. Lisan also offers contract manufacturing (maquila) and quality-control services.
| Import | Export |
|---|---|
|
Trade Records
148
|
Trade Records
147
|
|
Suppliers
17
|
Buyers
3
|
|
Latest Import Date
2026-08
|
Latest Export Date
2026-07
|
According to Topease's global trade data, LISAN S.A. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the LISAN S.A. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, LISAN S.A. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore LISAN S.A.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| DROMEX INTERNATIONAL S A | LISAN S.A. | 2922 | 24 | $186,500 | 3,420 | Los Angeles |
| AMERICHEM PHARMACEUTICAL CORP. | LISAN S.A. | 2816 | 24 | $186,500 | 3,420 | Los Angeles |
| ALBANGHU INC | LISAN S.A. | 2922 | 24 | $186,500 | 3,420 | Los Angeles |
| HELIANTUS | LISAN S.A. | 2507 | 24 | $186,500 | 3,420 | Los Angeles |
| KLOCKNER PENTAPLAST OF AMERICA | LISAN S.A. | 3920 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into LISAN S.A.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| DROGUERIA E IMPORTADORA ALEMANA | LISAN S.A. | 2309 | 24 | $186,500 | 3,420 | Los Angeles |
| EMMA DEL SOCORRO HOLMANN SAENZ VET PLUS | LISAN S.A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| NUTRO S.A | LISAN S.A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore LISAN S.A.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access LISAN S.A.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.